Abstract: The disclosure features a human milk cream composition as well as methods of making a human milk cream composition and using a human milk cream composition. In particular, the disclosure features a method of using a human milk cream composition to raise the caloric content of human milk.
Type:
Grant
Filed:
July 13, 2022
Date of Patent:
August 20, 2024
Assignee:
Prolacta BioScience, Inc.
Inventors:
Scott Elster, Joseph Fournell, Scott Eaker
Abstract: The present disclosure relates to human milk compositions and methods of making and using the same. In particular, the disclosure features methods of using human milk compositions to feed subjects before and/or after surgery or medical operations and that are useful in promoting recovery.
Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
Type:
Grant
Filed:
December 13, 2019
Date of Patent:
November 7, 2023
Assignee:
Prolacta Bioscience, Inc.
Inventors:
Joseph Fournell, Scott Eaker, Armando Montoya
Abstract: The disclosure features a human milk cream composition as well as methods of making a human milk cream composition and using a human milk cream composition. In particular, the disclosure features a method of using a human milk cream composition to raise the caloric content of human milk.
Type:
Grant
Filed:
May 15, 2019
Date of Patent:
August 23, 2022
Assignee:
Prolacta BioScience, Inc.
Inventors:
Scott Elster, Joseph Fournell, Scott Eaker
Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.
Type:
Application
Filed:
April 12, 2022
Publication date:
July 28, 2022
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
Abstract: The present disclosure relates to human milk compositions and methods of making and using the same. In particular, the disclosure features methods of using human milk compositions to feed subjects before and/or after surgery or medical operations and that are useful in promoting recovery.
Abstract: The disclosure features a human milk cream composition as well as methods of making a human milk cream composition and using a human milk cream composition. In particular, the disclosure features a method of using a human milk cream composition to raise the caloric content of human milk.
Type:
Grant
Filed:
March 5, 2014
Date of Patent:
September 21, 2021
Assignee:
Prolacta Bioscience, Inc.
Inventors:
Scott Elster, Joseph Fournell, Scott Eaker
Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
Type:
Application
Filed:
December 13, 2019
Publication date:
November 19, 2020
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Joseph FOURNELL, Scott EAKER, Armando MONTOYA
Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
Type:
Grant
Filed:
August 3, 2012
Date of Patent:
November 3, 2020
Assignee:
Prolacta Bioscience, Inc.
Inventors:
Joseph Fournell, Scott Eaker, Armando Montoya
Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
Type:
Grant
Filed:
October 17, 2017
Date of Patent:
December 17, 2019
Assignee:
Prolacta Bioscience, Inc.
Inventors:
Joseph Fournell, Scott Eaker, Armando Montoya
Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.
Type:
Application
Filed:
July 8, 2019
Publication date:
October 31, 2019
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
Abstract: The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.
Type:
Application
Filed:
November 14, 2018
Publication date:
March 28, 2019
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Elena M. Medo, Martin L. Lee, David J. Rechtman, Joseph Fournell
Abstract: The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.
Type:
Application
Filed:
November 14, 2018
Publication date:
March 14, 2019
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Elena M. MEDO, Martin L. LEE, David J. RECHTMAN, Joseph FOURNELL
Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.
Type:
Application
Filed:
November 14, 2018
Publication date:
March 14, 2019
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.
Type:
Application
Filed:
October 24, 2018
Publication date:
February 21, 2019
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Elena M. MEDO, Armando MONTOYA, Martin LEE, David RECHTMAN
Abstract: This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.
Type:
Application
Filed:
October 5, 2017
Publication date:
April 5, 2018
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Joseph FOURNELL, Scott EAKER, Scott ELSTER, David J. RECHTMAN
Abstract: The present invention relates to a method for treating raw human milk to produce treated human milk having undetectable levels of bacteria. The milk is skimmed to produce skim human milk then subjected to microfiltration to yield a filtrate which has undetectable levels of bacteria, including Bacillus cereus. The resultant human milk can be further processed, used and/or sold.
Type:
Application
Filed:
October 17, 2017
Publication date:
February 15, 2018
Applicant:
Prolacta Bioscience, Inc.
Inventors:
Joseph FOURNELL, Scott EAKER, Armando MONTOYA
Abstract: The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.
Type:
Grant
Filed:
August 30, 2007
Date of Patent:
October 6, 2015
Assignee:
PROLACTA BIOSCIENCE, INC.
Inventors:
Elena M. Medo, Armando Montoya, Martin Lee, David Rechtman
Abstract: This disclosure features human milk permeates and compositions containing the same obtained from fractionated whole human milk. The oligosaccharide rich permeate and permeate compositions of the present invention are useful as nutritional supplements for pre-term and full term infants, for establishing or maintaining gut flora and for treating the symptoms of inflammatory bowel disease.
Type:
Grant
Filed:
December 2, 2009
Date of Patent:
January 6, 2015
Assignee:
Prolacta Bioscience
Inventors:
Joseph Fournell, Scott Eaker, Scott Elster, David J. Rechtman
Abstract: The disclosure is related generally to methods for testing mammary fluid (including milk) to establish or confirm the identity of the donor of the mammary fluid. Such methods are useful in the milk-bank business to improve safety.
Type:
Grant
Filed:
September 10, 2018
Date of Patent:
October 6, 2020
Assignee:
Prolacta Bioscience, Inc.
Inventors:
Elena M. Medo, Martin L. Lee, David J. Rechtman